Otsuka (OTCMKTS:OTSKY – Get Free Report) is expected to post its resultson Wednesday, April 29th. Analysts expect Otsuka to post earnings of $0.4268 per share and revenue of $3.8021 billion for the quarter.
Otsuka Price Performance
Shares of OTSKY stock opened at $33.75 on Monday. The stock’s 50-day moving average is $33.90 and its 200 day moving average is $30.45. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67. Otsuka has a 1-year low of $21.64 and a 1-year high of $36.55. The company has a market cap of $36.25 billion and a P/E ratio of 14.67.
Analysts Set New Price Targets
A number of research firms have commented on OTSKY. Morgan Stanley upgraded Otsuka to an “overweight” rating in a research note on Friday, January 23rd. The Goldman Sachs Group cut Otsuka from a “strong-buy” rating to a “strong sell” rating in a research note on Friday, February 27th. Zacks Research upgraded Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. Finally, UBS Group upgraded Otsuka to a “hold” rating in a research note on Tuesday, January 27th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.
About Otsuka
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
Read More
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
